Exploring the structural requirements of fluorinated benzylidene-thiazolidinediones for selective antitrypanosomal activity.
Human and animal African trypanosomiasis remain serious parasitic diseases requiring the development of new therapeutics with improved efficacy and safety profiles. In this study, a series of novel heterocyclic derivatives based on previously identified thiazolidinedione scaffolds were designed, synthesized, and evalua...